Why the study?
Given the impact of cardiovascular conditions on COVID-19 outcomes, the study examined whether epicardial adipose tissue volume correlates with disease severity and mortality in severe and critical SARS-CoV-2 pneumonia.
Does higher epicardial adipose tissue volume predict increased 30-day in-hospital mortality and disease severity in patients with severe and critical COVID-19 pneumonia?
Does higher epicardial adipose tissue volume predict increased 30-day in-hospital mortality and disease severity in patients with severe and critical COVID-19 pneumonia?
Higher epicardial adipose tissue volume serves as a prognostic imaging biomarker for increased 30-day in-hospital mortality and disease severity in patients with severe COVID-19 pneumonia.
Answers are grounded in this paper and cite their sources.
Higher EATV was associated with increased 30-day mortality in severe COVID-19; leaves open incremental value over existing markers.
INTRODUCTION: Given the impact of cardiovascular conditions on COVID-19 outcomes, there is increasing interest in assessing risk factors like epicardial adipose tissue (EAT). EAT contributes to metabolic syndrome, which worsens cardiovascular health through inflammation and insulin resistance, and triples mortality risk in COVID-19 patients. This study examined the relationship between EAT volume (EATV) and clinical outcomes in severe and critical SARS-CoV-2 pneumonia, hypothesizing that higher EATV would correlate with increased severity and mortality. METHODS: This multicenter retrospective cohort study of 750 COVID-19 patients with severe or critical pneumonia explored the relationships between EATV, the pulmonary severity index (PSI), the Kirby index, and 30-day in-hospital mortality. Outcomes included Sequential Organ Failure Assessment, Acute Physiology and Chronic Health Evaluation IV, Charlson comorbidity index, Kirby index, PSI, and 30-day in-hospital mortality. This retrospective cohort study evaluates EATV as a prognostic factor for COVID-19 mortality. RESULTS: indicating a higher risk. DISCUSSION: Epicardial adipose tissue volume was linked to increased mortality in patients with severe and critical pneumonia, especially in the third tertile. It was also associated with higher pulmonary severity indices and 30-day in-hospital mortality. Clinicians should consider EATV alongside inflammatory biomarkers to improve patient stratification and potentially enhance outcomes through earlier intervention.
No takes yet. Share an insight, caveat, or question.
Jiménez-Zarazúa et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: